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Abstract
Background:  To quantitatively evaluate radiation-induced impaired oesophageal transit with
oesophageal transit scintigraphy and to assess the relationships between acute oesophagitis
symptoms and dysmotility.
Methods: Between January 1996 and November 1998, 11 patients affected by non-small-cell
carcinoma of the lung not directly involving the oesophagus, requiring adjuvant external beam
radiotherapy (RT) to the mediastinum were enrolled. Oesophageal transit scans with liquid and
semisolid bolus were performed at three pre-defined times: before (T0) and during radiation at 10
Gy (T1) and 30 Gy (T2). Two parameters were obtained for evaluation: 1) mean transit time
(MTT); and 2) ratio between peak activity and residual activity at 40 seconds (ER-40s). Acute
radiation toxicity was scored according to the joint EORTC-RTOG criteria. Mean values with
standard deviation were calculated for all parameters. Analysis of variance (ANOVA) tests and
paired t-Tests for all values were performed.
Results: An increase in the ER-40s from T0 to T1 or T2 was seen in 9 of 11 patients (82%). The
mean ER-40s value for all patients increased from 0.8306 (T0) to 0.8612 (T1) and 0.8658 (T2).
These differences were statistically significant (p < 0.05) in two paired t-Tests at T0 versus T2 time:
overall mean ER-40s and upright ER-40s (p = 0.041 and p = 0.032, respectively). Seven patients
(63%) showed a slight increase in the mean MTT value during irradiation but no statistically
significant differences in MTT parameters were found between T0, T1 and T2 (p > 0.05).
Conclusion:  Using oesophageal scintigraphy we were able to detect early alterations of
oesophageal transit during the third week of thoracic RT.
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Background
External beam RT to the mediastinum is generally recom-
mended in the treatment of a variety of thoracic tumours,
in either a curative or a palliative setting. The oesophagus
is often included in the radiation treatment volume. Acute
oesophagitis is therefore one of the most frequent side
effects and, particularly with the current trend for com-
bined modality therapy, can be severe enough to interrupt
the planned course of radiation therapy. Its pathophysiol-
ogy, however, remains poorly understood.
The main clinical signs of acute radiation oesophagitis are
dysphagia and odynophagia [1] that appear approxi-
mately during the third week of conventionally fraction-
ated RT (2 Gy/day, 5 days/week), with a median total dose
of 30 Gy [2]. The presence of these symptoms, which are
clinical manifestation of dyskinesia and mucositis respec-
tively [3], suggests that radiation-induced acute oesophag-
itis might be associated with altered organ motility. This
hypothesis was supported by the efficacy of prophylactic
pharmacological therapy consisting of Domperidone (a
prokinetic agent) and Nimesulide (a non-steroidal anti-
inflammatory) in delaying the onset and reducing the
duration of oesophageal side effects in patients undergo-
ing mediastinal irradiation [4].
A variety of studies have shown that irradiation of the
oesophagus causes early mucosal changes and late organ
dysmotility, fibrosis and stricture [5]. There is, however,
uncertainty over whether RT causes acute effects on
oesophageal motility or transit.
A number of well-conducted studies have been performed
in order to assess (with manometry, endoscopy, scintigra-
phy or radiography) the presence of impaired oesopha-
geal motility subsequent to irradiation. The results,
however, are conflicting, most likely reflecting differences
in study methodology and patient selection criteria.
Radionuclide oesophageal transit studies have been
shown to be effective in the evaluation of oesophageal
motility disorders [6] even when compared with oesopha-
geal manometry, the current gold standard technique
[7,8]. The high sensitivity of this method in detecting
impaired oesophageal motility in patients with systemic
sclerosis has been well demonstrated [9].
The aim of this study was to evaluate oesophageal transit
time parameters by oesophageal scintigraphy to test the
hypothesis that patients undergoing mediastinal RT may
develop early oesophageal dysmotility and to assess the
relationships between acute oesophagitis symptoms and
dysmotility.
Methods
Study population and radiotherapy course
Between January 1996 and November 1998, a study was
conducted on 11 patients (all males, mean age 59 years,
range 48–75) affected by non-small-cell lung cancer not
directly involving the oesophagus, treated with adjuvant
external beam RT to the mediastinum. No patients with
diffuse advanced malignant disease were enrolled in the
study as they may have motility disorders of their gas-
trointestinal tract in the absence of demonstrable struc-
tural lesions [10,11].
All patients were treated with multiple field techniques
with computed treatment planning and were selectively
enrolled because they were considered at high risk of
developing clinical radiation oesophagitis due to at least
12 cm cranial-caudal length of oesophagus being
included in the planning target volume (PTV). For all
patients the dose prescribed to the PTV (including medi-
astinal nodes and adjacent normal oesophagus) was 46
Gy in 23 fractions of 2 Gy each over 4 and half weeks. No
patient received concomitant or neoadjuvant chemother-
apy.
Symptom Assessment
The incidence of oesophagitis during RT was evaluated
twice weekly on the basis of clinical-anamnestic monitor-
ing with reference to the joint European Organisation for
Research and Treatment of Cancer and Radiation Therapy
Oncology Group (EORTC-RTOG) scoring criteria [12]
(Table 1). In all patients, before irradiation, barium swal-
low and a preliminary clinical-anamnestic examination
excluded morphological abnormalities while scintigraphy
failed to reveal alterations of oesophageal transit prior to
Table 1: Joint EORTC-RTOG acute toxicity scoring criteria
Score Symptoms Suggested Therapy
0 absence of alterations of the basal state
1 slight dysphagia and/or odynophagia topic anaesthetic and/or no-narcotic analgesics, light diet
2 moderate dysphagia and/or odynophagia narcotics analgesics, diet based on purées or liquids
3 severe dysphagia and/or odynophagia with dehydration and weight 
loss >15%
nasogastric small probe for nutrition, liquid infusion or hyper-
caloric diet
4 complete occlusion/obstruction, ulceration, perforation, (fistulae)
European Organisation for Research and Treatment of Cancer and Radiation Therapy Oncology Group (EORTC-RTOG)BMC Gastroenterology 2008, 8:51 http://www.biomedcentral.com/1471-230X/8/51
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radiation treatment. Endoscopic studies were not per-
formed during the radiation treatment because of their
poor compliance in patients suffering from acute radia-
tion oesophagitis.
Oesophageal Scintigraphy
The oesophageal scintigraphy studies were performed at
three pre-defined times: before the beginning (T0) and at
the end of the first and the third week of the RT course
with a delivered radiation dose to the oesophagus of 10
Gy (T1) and 30 Gy (T2).
Oesophageal scintigraphy was performed according to the
standards suggested by Klein HA in his comprehensive
review [13]. The procedure was conducted using both liq-
uid and semi-solid bolus. The liquid bolus, consisting of
5 ml water marked with 99mTc-DTPA (technetium-99 m
diethylene triamine penta-acetic acid), was administered
both in the upright and supine position while the semi-
solid radioactive meal, consisting of 10 ml of whipped egg
albumen marked with 99mTc-DTPA to achieve an activity
concentration of 37 MBq/mL, was used for the third
acquirement, only in upright position. Labelling effi-
ciency of the egg albumen mixed with 99mTc-DTPA was
90%, and the radiolabel remained "fixed" on the semi-
solid meal for an immediate usage.
All subjects were examined after 6 hours of fasting.
Imaging was performed using a large-field-of-view
gamma camera fitted with a low-energy general-purpose
parallel-hole (LEAP) collimator (Orbiter 75, Siemens,
Erlangen). Computer analysis was performed both with a
dedicated on-line workstation and with a post-processing
PC workstation.
For each acquisition, the gamma camera was positioned
ahead of the patient in the anterior projection. The field of
view covered an area including the hypopharynx,
oesophagus and stomach.
Oesophageal scintigraphy was constituted of three differ-
ent phases. Radioactive reference points were positioned
at the level of the jugular fossa and xiphoid, using radiola-
belled markers, during the first phase (90 seconds). Then,
in the second phase (30 seconds), the computer was set to
acquire a dynamic study comprising 60 half-second
frames followed, in the last phase, by 10-seconds frames
for the succeeding 9 minutes. The overall duration of the
whole examination (sum of the three phases) was 11 min-
utes.
The subject was refrained from swallowing until
prompted with the radioactive meal placed in the mouth.
When the computer was activated for study acquisition,
the patient was asked to perform a single swallow and to
abstain from swallowing during the following acquisition
period. The study was repeated and if there was evidence
or signs of possible additional swallows, a drink of not-
radiomarked water was administered to the patient, at the
end of the study, to remove any residual activity in the
oesophageal lumen, confirmed by visual assessment on
the gamma camera's video.
Regions of interest (ROI) were outlined for the mouth,
whole oesophagus and stomach.
According to Klein and Wald [14] the study was processed
using a standard, software program designed for the anal-
ysis of dynamic scintigraphy implemented with a propri-
etary algorithm for oesophageal transit evaluation with
computer-generated condensed dynamic images recon-
struction. As the transit process involves only the
oesophageal cranio-caudal dimension (lateral motion is
of no concern), the dynamic image data was condensed
into a single image with one spatial dimension and one
temporal dimension (vertical and horizontal respec-
tively), allowing an easy calculation of the time-activity
curves (Figure 1, 2 and 3).
After the calculation of the time-activity curves for each
patient's ingestion, two parameters were obtained for
evaluation: peak and 40 seconds residual activity ratio
(ER-40s) and mean time of transit (MTT). These parame-
ters were calculated for liquid bolus in upright and supine
position and for semi-solid bolus in upright position
only. The mean ER-40s and MTT values from the three dif-
ferent acquisitions for each patient and the mean ER-40s
and MTT values from the whole database study set (mean
of 33 acquisitions at 3 different times) were also calcu-
lated. The summary of the parameters obtained is
described in Table 2.
Data Analysis
Mean values with standard deviation were calculated for
all parameters. A paired t-test for each couple of data and
for each type was performed. Also an analysis of variance
(ANOVA) test was performed to assess the three sets of
data (T0, T1 and T2) for each parameter. The study aimed
to perform a repeated measurement of the sample popu-
lation (to compare the measurements of the same people
across time). Thus ANOVA for repeated measurements
has been used in addition to "normal ANOVA".
Results
The procedure was extremely well tolerated and all 11
patients were evaluable at T1 and T2. All patients com-
plained of slight to moderate dysphagia and/or
odynophagia at the end of the third week of the radiation
course (T2, 30 Gy) but no patients developed grade 2BMC Gastroenterology 2008, 8:51 http://www.biomedcentral.com/1471-230X/8/51
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acute toxicity. Therefore no relationship was found
between these symptoms and abnormal oesophageal
transit in terms of time of appearance or degree of toxicity.
There was no evidence of oesophageal gastric reflux in any
examined patients.
Data from the study acquisition is shown in Table 3.
Repeated measurements ANOVA test results (comparing
T0, T1, and T2) are shown in Table 4.
Paired t-Tests results for T0 vs T1, T0 vs T2 and T1 vs T2 are
shown in Table 5.
Residual activity ratio at 40 seconds (ER-40s)
Data from supine and upright position study with liquid
and semi-solid meal were available for all patients and for
each of them a mean value of three data sets was also cal-
culated (mean ER-40s, Fig. 4).
An increased mean ER-40s from T0 to at least one of the
further studies was seen in 9 of 11 patients (81.8%). An
increased ER-40s from T0 to at least one of the further
studies was also seen in 9 of 11 patients (81.8%) for the
acquisition with liquid bolus in upright and supine posi-
tion while it was noted in only 7 of 11 patients (63.6%)
with semi-solid meal.
The mean ER-40s for the whole database study set for all
patients passed from a value of 0.8306 (SD 0.1052) at T0
to 0.8612 (SD 0.0739) at T1 and further increased to
0.8658 (SD 0.0759) at T2. The mean ER-40s for all
patients passed from a value of 0.8318 (SD 0.0687) at T0
to 0.8618 (SD 0.0584) at T1 and further increased to
0.8655 (SD 0.0719) at T2. The mean upright position ER-
40s for all patients passed from a value of 0.8427 (SD
0.0910) at T0 to 0.8900 (SD 0.0471) at T1 and to 0.8827
(SD 0.0648) at T2. The mean supine ER-40s for all
Oesophageal scintigraphy: Dynamic condensed oesophageal images before radiation therapy (normal transit) Figure 1
Oesophageal scintigraphy: Dynamic condensed oesophageal images before radiation therapy (normal transit).BMC Gastroenterology 2008, 8:51 http://www.biomedcentral.com/1471-230X/8/51
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patients passed from a value of 0.7809 (SD 0.1217) at T0
to 0.8264 (SD 0.0866) at T1 and further increased to
0.8491 (SD 0.0979) at T2. By contrast, the mean semi-
solid bolus ER-40s for all patients passed from a value of
0.8682 (SD 0.0887) at T0 to 0.8673 (SD 0.0740) at T1
and further decreased to 0.8655 (SD 0.0633) at T2.
Thus at the 0.05 significance level all the differences pre-
viously described between the various mean ER-40s in
supine and upright position with liquid and semi-solid
bolus at T0, T1 and T2 were not significantly different (p
> 0.05) at both the standard and repeated measurement
ANOVA tests.
At paired t-Test analysis two tests were statistically signifi-
cant at T0 vs T2 time comparison: respectively, Overall
mean ER-40s (p = 0.041) and Upright ER-40s (p = 0.032).
Mean Transit Time (MTT)
Data from supine and upright position study with liquid
and semi-solid meal were available for all patients and for
each of them a mean value of three data sets was also cal-
culated (mean MTT, Fig. 5).
An increased mean MTT from T0 to at least one of the fur-
ther studies was seen in 7 of 11 patients (63.6%). An
increased MTT from T0 to at least one of the further stud-
ies was also seen in 7 of 11 patients (63.6%) for the acqui-
sition with liquid bolus in upright position and 8 of 11
(72.7%) patients for the supine position, while it was
noted in only 6 of 11 patients (54.5%) with semi-solid
meal.
The mean MTT for the whole database study set for all
patients passed from a value of 5.6318 (SD 4.7392) at T0
to 5.1776 (SD 4.5231) at T1 and to 5.1812 (SD 3.3632)
Oesophageal scintigraphy: Dynamic condensed oesophageal images during radiation therapy (slightly altered transit at 10 Gy) Figure 2
Oesophageal scintigraphy: Dynamic condensed oesophageal images during radiation therapy (slightly altered 
transit at 10 Gy).BMC Gastroenterology 2008, 8:51 http://www.biomedcentral.com/1471-230X/8/51
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at T2. The mean MTT for all patients decreased from a
value of 5.6300 (SD 3.1859) at T0 to 5.1782 (SD 2.6908)
at T1 and to 5.1818 (SD 2.7048) at T2. The mean upright
position MTT for all patients passed from a value of
4.9391 (SD 4.8675) at T0 to 3.0255 (SD 1.2001) at T1
and to 4.4218 (SD 3.1062) at T2. The mean supine MTT
for all patients passed from a value of 6.9864 (SD 5.6917)
at T0 to 8.5318 (SD 5.7274) at T1 and decreased to 6.4391
(SD 3.9604) at T2. The mean semi-solid bolus MTT for all
patients passed from a value of 4.9700 (SD 3.5716) at T0
to 3.9755 (SD 3.4877) at T1 and then increased to 4.6827
(SD 2.8662) at T2.
Oesophageal scintigraphy: Dynamic condensed oesophageal images during radiation therapy (distinctly altered transit at 30 Gy) Figure 3
Oesophageal scintigraphy: Dynamic condensed oesophageal images during radiation therapy (distinctly 
altered transit at 30 Gy).
Table 2: List of analysed parameters
1 ER-40s and MTT in upright position with liquid bolus for each patient.
2 ER-40s and MTT in supine position with liquid bolus for each patient.
3 ER-40s and MTT in upright position with semisolid bolus for each patient.
4 Mean ER-40s and MTT value from the 3 previously described parameters for each patient.
5 Mean of all the ER-40s and MTT values for the whole database study set (33 acquisition at 3 different times).BMC Gastroenterology 2008, 8:51 http://www.biomedcentral.com/1471-230X/8/51
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At the 0.05, significance level, all differences previously
described between the various mean MTT in supine and
upright position with liquid and semi-solid bolus at T0,
T1 and T2 were not significantly different (p > 0.05) for
both ANOVA and paired t-Tests.
Discussion
The relationships between acute and chronic radiation
side effects are controversial and the prediction of their
severity is difficult [15]. Although oesophageal symptoms
are common during adjuvant thoracic RT, the effects of
irradiation on oesophageal function are still to be
assessed.
Oesophagitis arises in at least two-thirds of patients
undergoing mediastinal RT. EORTC-RTOG grade 2 and
grade 3 oesophagitis occurs in 12% and 3% of patients
respectively [16]. In the majority of patients, it's onset is
Table 3: Study acquisition's data (values are in seconds for MTT and <ratio> for ER-40s)
Time T0 T1 T2
Patients Study ER-40s MTT ER-40s MTT ER-40s MTT
1 upright 0.90 3.01 0.96 1.98 0.91 4.41
supine 0.91 1.70 0.90 2.63 0.93 1.75
upright ss 0.84 6.13 0.87 2.89 0.81 10.50
mean 0.89 3.61 0.91 2.50 0.88 5.55
2 upright 0.80 2.00 0.88 2.39 0.89 2.03
supine 0.82 4.68 0.91 9.98 0.88 2.03
upright ss 0.90 8.12 0.91 1.80 0.92 2.11
mean 0.84 4.93 0.90 4.73 0.89 2.05
3 upright 0.91 2.23 0.84 5.27 0.92 5.00
supine 0.79 8.15 0.81 14.57 0.81 7.49
upright ss 0.85 4.01 0.86 2.51 0.87 4.01
mean 0.85 4.80 0.84 7.45 0.86 5.50
4 upright 0.86 2.03 0.90 3.00 0.92 4.00
supine 0.84 3.06 0.93 4.34 0.94 6.00
upright ss 0.95 1.87 0.93 2.87 0.90 4.00
mean 0.88 2.32 0.92 3.41 0.92 4.67
5 upright 0.69 15.40 0.88 2.80 0.80 5.77
supine 0.66 14.45 0.81 8.17 0.76 10.27
upright ss 0.83 5.66 0.89 3.16 0.76 7.71
mean 0.73 11.83 0.86 4.71 0.77 7.92
6 upright 0.70 13.30 0.78 5.40 0.72 12.59
supine 0.82 3.47 0.68 12.51 0.60 14.68
upright ss 0.63 13.90 0.66 13.70 0.75 8.34
mean 0.72 10.22 0.71 10.54 0.69 11.87
7 upright 0.87 1.87 0.92 2.20 0.88 4.87
supine 0.81 3.13 0.90 6.17 0.87 2.15
upright ss 0.93 3.29 0.84 6.78 0.88 3.98
mean 0.87 2.76 0.89 5.05 0.88 3.66
8 upright 0.97 2.02 0.90 2.70 0.93 1.13
supine 0.65 15.39 0.83 2.23 0.92 8.95
upright ss 0.93 1.95 0.93 1.92 0.91 2.11
mean 0.85 6.45 0.89 2.28 0.92 4.07
9 upright 0.79 6.66 0.90 2.80 0.91 1.52
supine 0.85 2.15 0.83 6.10 0.86 6.83
upright ss 0.88 3.16 0.88 2.90 0.92 2.35
mean 0.84 3.99 0.87 3.93 0.90 3.57
10 upright 0.84 3.26 0.91 2.86 0.91 4.40
supine 0.52 16.44 0.67 21.29 0.87 6.80
upright ss 0.88 4.82 0.89 2.82 0.88 4.00
mean 0.75 8.17 0.82 8.99 0.89 5.07
11 upright 0.94 2.55 0.92 1.88 0.92 2.92
supine 0.92 4.23 0.82 5.86 0.90 3.88
upright ss 0.93 1.76 0.88 2.38 0.92 2.40
mean 0.93 2.85 0.87 3.37 0.92 3.07BMC Gastroenterology 2008, 8:51 http://www.biomedcentral.com/1471-230X/8/51
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during the third week of the RT course. Any concomitant
chemotherapy and simultaneous exposure of the organ to
exogenous infectious agents by micro-traumatising agents
(mainly some foods) increases the risk of radiation toxic-
ity.
Around one third of patients develop clinical symptoms
without histological changes [17] and endoscopic and
radiographic identification and quantification of subtle
disorders remains a problem.
Patients with clinical signs of acute radiation oesophagitis
often have negative single-contrast oesophagograms [18]
and only in a few positive cases was a thin indentation of
the barium column demonstrated. Double contrast radio-
logical examination may reveal a variable segment of
oesophageal narrowing with multiple discrete ulcers or a
distinctive granular appearance of the mucosa within a
known irradiated volume, suggesting the diagnosis of
radiation oesophagitis [19], but a quantitative evaluation
of altered oesophageal transit cannot be assessed.
Endoscopic studies may show oedema and vulnerability
of the mucosa without erosion in patients with clinical
signs of radiation-induced oesophagitis [20], but addi-
tional dynamic visual analysis might be helpful in diag-
nosing early changes.
Oesophageal scintigraphy is a well-established nuclear
imaging method for the detection of motility disorders
that has been used in a variety of clinical situations such
as systemic sclerosis, oesophageal spasm, achalasia [21],
diabetes mellitus [22], reflux disease and dysphagia of
unclear origin. It is a non-invasive diagnostic method with
a low radiation dose and offers the possibility of quantita-
tive analysis.
The clinical, value of radionuclide oesophageal transit
measurements in relation to established oesophageal
motility investigations, was assessed by de Caestecker et
al. [23]. In their experience of 150 patients, the overall
sensitivity in detecting oesophageal dysmotility was 75%
for radionuclide transit measurements, 83% for manom-
etry and 30% for conventional barium radiology. In 18
patients oesophageal scans identified abnormalities not
detected by manometry. The authors concluded that radi-
onuclide transit measurements were a useful test for
patients with suspected oesophageal motility disorders,
providing additional information which complemented
Table 4: Repeated measurements ANOVA (comparing T0, T1, 
and T2)
p-value (based on Wilk's lambda)
Overall mean ER-40s P = 0.117
Overall mean MTT P = 0.815
Upright ER-40s P = 0.113
Upright MTT P = 0.244
Supine ER-40s P = 0.383
Supine MTT P = 0.556
Upright ss ER-40s P = 0.986
Upright ss MTT P = 0.501
Table 5: Paired t-Tests results
T0 vs T1 T0 vs T2 T1 vs T2
Overall mean ER-40s P = 0.071 P = 0.041 P = 0.788
Overall mean MTT P = 0.611 P = 0.522 P = 0.996
Upright ER-40s P = 0.069 P = 0.032 P = 0.614
Upright MTT P = 0.195 P = 0.658 P = 0.090
Supine ER-40s P = 0.180 P = 0.159 P = 0.359
Supine MTT P = 0.431 P = 0.752 P = 0.270
Upright ss ER-40s P = 0.943 P = 0.868 P = 0.921
Upright ss MTT P = 0.227 P = 0.765 P = 0.505
Oesophageal scintigraphy: Residual activity ratio at 40 sec- onds (ER-40s) mean values Figure 4
Oesophageal scintigraphy: Residual activity ratio at 
40 seconds (ER-40s) mean values.
Oesophageal scintigraphy: Mean transit time (MTT) mean  values Figure 5
Oesophageal scintigraphy: Mean transit time (MTT) 
mean values.BMC Gastroenterology 2008, 8:51 http://www.biomedcentral.com/1471-230X/8/51
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oesophageal manometry, although it did have limitations
as a screening test. The validity of non-invasive oesopha-
geal transit scintigraphy to quantitatively assess gastroin-
testinal motor dysfunction has been supported by a
number of other studies and reviews [24-27].
According to Holloway et al. [28], the main limitation of
the radionuclide transit test may be a consequence of
using a liquid bolus. This successfully identifies motor
disorders characterized by defective peristaltic progression
but fails to discover disorders in which peristalsis is intact,
probably because of the small number of swallow
sequences tested.
Dysphagia and odynophagia are the symptoms most
commonly experienced by patients with acute radiation
oesophagitis [1], but objective documentation of early
dysphagia remains difficult. The rate of mild (grade 1)
toxicity ranges between 60% and 100% in published
series. Dysphagia and odynophagia are clinical manifesta-
tions of dyskinesia and mucositis, respectively, suggesting
a potential role for oesophageal transit studies in provid-
ing prognostic data for early treatment phase evaluation
of radiation oesophagitis.
In order to further clarify the pathogenesis of these seque-
lae, Yeoh et al. [29] used barium swallow, endoscopy,
combined radionuclide scintigraphy and oesophageal
manometry to evaluate eight patients before, during and
after mediastinal irradiation for potentially curable intra-
thoracic malignant disease. The authors concluded that
post-radiation oesophageal symptoms are not a result of
altered oesophageal motility or transit but may reflect
increased mucosal sensitivity.
The absence of observed abnormal peristaltic response
conflicts with the previous prospective study of LaManna
et al. [30] suggesting that post-radiation oesophageal
symptoms may reflect disordered oesophageal motility as
evaluated by radionuclide oesophageal transit scintigra-
phy.
This discrepancy may be attributed to differences in meth-
odology of the studies and patient selection criteria, both
inducing prolongation of the oesophageal transit time in
the LaManna et al. study. In the Yeoh et al. study, the
absence of significant changes in oesophageal motility
despite the development of symptoms may have been
influenced by the inclusion of 3 patients (37%) with car-
cinoma of the breast. The dose to the oesophagus in those
patients was approximately one third of the dose received
by the other participants on the study. In addition, a
number of patients had underlying abnormalities in
oesophageal function which may have masked any small
increase in oesophageal transit times.
Oesophageal scintigraphy has also been found to be a sen-
sitive tool for the evaluation of dysphageal symptoms and
quantification of the effect of local analgesic treatment
during mediastinal RT in a study by Brandt-Mainz et al.
[31].
The exact role of oesophageal transit scintigraphy in the
evaluation of gastrointestinal motility disease remains
controversial. It appears useful when oesophageal man-
ometry is poorly tolerated, such as in patients suffering
from acute radiation oesophagitis.
There is a large dependence of measurements on multiple
variables such as the patient's position, projection, bolus
consistency and volume, isotope, number of independent
wet swallows, analytical parameters used, and considera-
tion of age. [32]. Therefore a protocol based on both pub-
lished data and accumulated local experience is
recommended and normal ranges should be defined in
one's own laboratory.
The emptying rate (ER) and the mean transit time (MTT)
are among the most commonly used parameters for eval-
uation of oesophageal transit and have already been sug-
gested for the assessment of radiation related oesophageal
disorders (Brandt-Mainz et al.).
The originality of our study lies in the evaluation of
oesophageal transit time parameters by a non-invasive
and well-tolerated method of oesophageal scintigraphy.
We hypothesised that patients submitted to mediastinal
RT, whether symptomatic or not, might have early
impaired oesophageal transit evaluable with this tech-
nique.
One of the main strengths of our study, when compared
to previous studies, is the homogeneous sample popula-
tion and treatment technique. All patients received 46 Gy
to at least a 12 cm length of oesophagus with a uniform
radiation technique and fields. Given the significant vol-
ume of oesophagus contained within the full dose region,
all patients were at high risk of developing radiation-
induced oesophagitis. All patients did, infact, develop
grade 1 toxicity during the third week of treatment and all
were symptomatic at the time of the T2 study. No patients
suffered from grade 2 or 3 radiation oesophagitis. This
was most likely due to the absence of concomitant chem-
otherapy and the lower total dose of irradiation used in
the adjuvant setting.
An additional strength of our study is in the timing of
oesophageal scintigraphy during the RT course. To our
knowledge, this is the largest study of oesophageal transit
during RT and the only one in which the scintigraphy is
performed at the end of the first and the third week of RT,BMC Gastroenterology 2008, 8:51 http://www.biomedcentral.com/1471-230X/8/51
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with the aim of assessing early alterations. The T2 study
aimed to detect changes in oesophageal motility during or
soon after the symptoms of oesophagitis would generally
appear (i.e. around the third week). By contrast, the T1
study was performed after only one week of RT in an
attempt to identify any earlier signs of dysmotility that
may predict for the subsequent development of sympto-
matic acute oesophagitis. The reason to perform this early
(T1) documentation of transit was also supported by stud-
ies of fractionated RT in dogs showing that gastrointesti-
nal motility changes occur within 48 hours of the
initiation of therapy [33,34].
A limitation of this study is the lack of a comparison with
manometry, which has been considered the most sensi-
tive method to detect impaired oesophageal motility and
lower oesophageal sphincter dysfunction. Kjellen et al.,
however, have reported on the utility of oesophageal scin-
tigraphy in 16 patients with symptomatic dysphagia but
having normal manometry, acid perfusion, acid clearance
and pH reflux tests [35]. They concluded that scintigraphy
could be regarded as a valuable complement in the objec-
tive documentation of dysphagia when other diagnostic
methods fail.
Our study found a trend from T0 to further studies in the
mean ER-40s value and this was confirmed in the detailed
analysis in 9 of 11 patients (81.8%). These differences
were not statistically significant (p > 0.05) at ANOVA but
two parameters, overall mean ER-40s (p = 0.041) and
upright ER-40s (p = 0.032), had changes between the
baseline study (T0) and the study performed after three
weeks of treatment (T2) which were statistically signifi-
cant at the paired t-Test analysis.
We acknowledge that the statistical significance of our
results is limited despite our homogeneous sample popu-
lation and treatment technique. However, in view of the
high variation in measurements between people, a large
sample size would be needed to draw further conclusions.
We believe there would be little chance of detecting some-
thing more (ie. ANOVA or p < 0.002 with Bonferroni
paired t-Tests) with further studies.
Finally, our study was designed about 10 years ago. Since
then indications for adjuvant or radical treatment of non-
small-cell lung cancer have changed resulting in a dra-
matic increase in the use of sequential and concomitant
chemotherapy with conformal RT and a more limited vol-
ume of oesophagus being irradiated (though often to a
higher dose). Therefore, it is unlikely that a similar sub-
group of patients will be available in the near future for
enrolment in a comparable clinical trial as further studies
will most likely focus on the effects and changes due to
intensive combined modality treatments.
Conclusion
In conclusion, this is one of the few prospective studies
examining the pathogenesis of oesophageal sequelae
from mediastinal irradiation. Our study may be limited
by the lack of endoscopic and manometric data, however,
to our knowledge it is the largest and most homogeneous
series of patients studied in this manner. Moreover, it is
unique in studying patients prior to radiation exposure
and early in the course of treatment before symptoms
appear. Our results confirm that oesophageal scintigraphy
can show early alterations of oesophageal transit during
the third week of thoracic RT. We are aware that the statis-
tically significance of our results is limited in spite of the
best efforts to ensure a very homogeneous sample popu-
lation and treatment technique. However, in view of the
sample size needed for further conclusions and the very
high variation of the measurements between people there
is little chance to detect something more (ie. ANOVA or p
< 0.002 with Bonferroni paired t-Tests) with further stud-
ies.
Finally, our study was designed about 10 years ago. Since
then indications for adjuvant or radical treatment of non-
small-cell lung cancer have changed resulting in a dra-
matic increase in the use of sequential and concomitant
chemotherapy with radiation therapy and a more limited
irradiation of the oesophagus, although with sometimes
higher doses to small volume of the organ. Therefore it is
unlikely that a similar subgroup of patients will be availa-
ble in the near future for enrolment in a comparable clin-
ical trial as further studies will most likely focus on the
effects and changes due to intensive combined modality
treatments.
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